Key result
Abnormal angiopoietin-Tie-2 signaling participates in pericyte/endothelial cell dissociation during early diabetic retinopathy, presenting a potential therapeutic target.
This review highlights the role of the pericyte-Angiopoietin-Tie-2 system in diabetic retinopathy and its potential as a therapeutic target.
May support Tie-2 pathway targeting in early diabetic retinopathy; leaves open clinical validation in prospective trials.
Pericytes are distinctive regulators of vascular morphologenesis and function during vascular development and homeostasis. Pericytes have recently come into focus as implications of aberrant interactions between pericytes and endothelial cells in number of pathological angiogenesis conditions, including diabetic retinopathy and tumor angiogenesis. Pericyte dropout is a hallmark of early diabetic retinopathy. Abnormal angiopoietin (Ang)-Tie-2 signaling is one principal system participating in pericyte/endothelial cell dissociation during early stages of diabetic retinopathy. Angiopoietin 2 (Ang-2) is among the relevant growth factors induced by hypoxia and plays an important role in the initiation of retinal neovascularization and cause pericyte loss. Furthermore, high levels of VEGF synergize Ang-Tie-2 signaling during the development of diabetic retinopathy. An accelerated rate of clinical development Ang-Tie-2-manipulating drugs requests a better mechanistic understanding the connection between pericytes and Ang-Tie-2 systems both under normal and disease conditions. We summarize recent advances in pericyte study in conjunction with Ang-Tie-2 signaling and also discuss possible therapeutic strategies for diabetic retinopathy by targeting pericytes through manipulating Ang-Tie-2 signaling.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2012) conducted a review in Diabetic Retinopathy. Ang-Tie-2 signaling manipulation was evaluated. Abnormal angiopoietin-Tie-2 signaling participates in pericyte/endothelial cell dissociation during early diabetic retinopathy, presenting a potential therapeutic target.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: